您当前所在的位置:首页 > 产品中心 > 产品信息
Pirbuterol_分子结构_CAS_38677-81-5)
点击图片或这里关闭

Pirbuterol

产品号 DB01291 公司名称 DrugBank
CAS号 38677-81-5 公司网站 http://www.ualberta.ca/
分子式 C12H20N2O3 电 话 (780) 492-3111
分子量 240.2988 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 1145

产品价格信息

请登录

产品别名

标题
Pirbuterol
IUPAC标准名
6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
IUPAC传统名
pyrbuterol
商标名
Maxair
别名
Pirbuterolum [inn-latin]
Pirbuterol hydrochloride

产品登记号

PubChem SID 46506379
CAS号 38677-81-5
PubChem CID 4845

产品性质

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.

The pharmacologic effects of beta adrenergic agonist drugs, including pirbuterol, are at least in proof attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (AlP) to cyclic-3? ,5?-adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.
Indication For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible bronchospasm including asthma.
Pharmacology Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.
Toxicity As with all sympathomimetic aerosol medication, cardiac arrest and even death may be associated with abuse of pirbuterol.
Affected Organisms
Humans and other mammals
Half Life The plasma half-life measured after oral administration is about two hours.
External Links
RxList
Drugs.com

参考文献